Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Praveen PN Rao & Tarek Mohamed. (2011) Current and emerging “at-site” pain medications: a review. Journal of Pain Research 4, pages 279-286.
Read now
Read now
Matthias Karst & Sonja Wippermann. (2009) Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective. Expert Opinion on Investigational Drugs 18:2, pages 125-133.
Read now
Read now
Simon J Read & Andy Dray. (2008) Osteoarthritic pain: a review of current, theoretical and emerging therapeutics. Expert Opinion on Investigational Drugs 17:5, pages 619-640.
Read now
Read now
Yuan Cheng & Stephen A Hitchcock. (2007) Targeting cannabinoid agonists for inflammatory and neuropathic pain. Expert Opinion on Investigational Drugs 16:7, pages 951-965.
Read now
Read now
Articles from other publishers (47)
Yanli Qiu, Yitian Zhao, Tao Hu, Meifang Yang, Fei Li, Cuixia Li, Weiliang Gu, Xiaodi Yang, Suwen Zhao & Houchao Tao. (2023) Development of Yin-Yang ligand for cannabinoid receptors. Bioorganic Chemistry 133, pages 106377.
Crossref
Crossref
E. Richet, L. Ferret, L. Gaboriau, P. Charpentier, L. Dujardin, J. Fulcrand & A. Boursier. (2022) Utilisation du dronabinol dans le traitement des douleurs neuropathiques réfractaires : retour d’expérience des patients suivis dans un Centre d’évaluation et de traitement de la douleur. Annales Pharmaceutiques Françaises.
Crossref
Crossref
Olga Pol. 2022. Carbon Monoxide in Drug Discovery. Carbon Monoxide in Drug Discovery
497
510
.
Keith A. Kwan Cheung, Murray D. Mitchell & Helen S. Heussler. (2021) Cannabidiol and Neurodevelopmental Disorders in Children. Frontiers in Psychiatry 12.
Crossref
Crossref
Paul Clayton, Mariko Hill, Nathasha Bogoda, Silma Subah & Ruchitha Venkatesh. (2021) Palmitoylethanolamide: A Natural Compound for Health Management. International Journal of Molecular Sciences 22:10, pages 5305.
Crossref
Crossref
Olga Pol. (2020) The role of carbon monoxide, heme oxygenase 1, and the Nrf2 transcription factor in the modulation of chronic pain and their interactions with opioids and cannabinoids. Medicinal Research Reviews 41:1, pages 136-155.
Crossref
Crossref
Vitor A.N. Bragança, Tiago G. França, Ana C.S.P.S. de Jesus, Ivanete C. Palheta, Fernanda P.A. Melo, Paulo A.P.F.G. Neves, Anderson B. Lima & Rosivaldo S. Borges. (2020) Impact of conformational and solubility properties on psycho-activity of cannabidiol (CBD) and tetrahydrocannabinol (THC). Chemical Data Collections 26, pages 100345.
Crossref
Crossref
Renata C.M. Ferreira, Marina G.M. Castor, Fabiana Piscitelli, Vincenzo Di Marzo, Igor D.G. Duarte & Thiago R.L. Romero. (2018) The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine. The Journal of Pain 19:5, pages 487-495.
Crossref
Crossref
R.S. Borges & A.B.F. da Silva. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
e122
e130
.
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
15
64
.
Jakub Fichna, JodiAnne T. Wood, Malvina Papanastasiou, Subramanian K. Vadivel, Piotr Oprocha, Maciej Sałaga, Marta Sobczak, Anna Mokrowiecka, Adam I. Cygankiewicz, Piotr K. Zakrzewski, Ewa Małecka-Panas, Wanda M. Krajewska, Piotr Kościelniak, Alexandros Makriyannis & Martin A. Storr. (2013) Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study. PLoS ONE 8:12, pages e85073.
Crossref
Crossref
Rosivaldo Borges, João BatistaJr.Jr., Rommel Viana, Ana Baetas, Ednilsom Orestes, Marcieni Andrade, Káthia Honório & Albérico da Silva. (2013) Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants. Molecules 18:10, pages 12663-12674.
Crossref
Crossref
C. G. Stott, L. White, S. Wright, D. Wilbraham & G. W. Guy. (2012) A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray. European Journal of Clinical Pharmacology 69:5, pages 1135-1147.
Crossref
Crossref
Carmen La Porta, Simona Andreea Bura, Auxiliadora Aracil-Fernández, Jorge Manzanares & Rafael Maldonado. (2013) Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate. Pain 154:1, pages 160-174.
Crossref
Crossref
Kathryn A. Seely, Lisa K. Brents, Lirit N. Franks, Maheswari Rajasekaran, Sarah M. Zimmerman, William E. Fantegrossi & Paul L. Prather. (2012) AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies. Neuropharmacology 63:5, pages 905-915.
Crossref
Crossref
Julia M. Adam, John K. Clark, Keneth Davies, Kathryn Everett, Ruth Fields, Stuart Francis, Fiona Jeremiah, Takao Kiyoi, Maurice Maidment, Angus Morrison, Paul Ratcliffe, Alan Prosser, Jurgen Schulz, Grant Wishart, James Baker, Susan Boyce, Robert Campbell, Jean E. Cottney, Maureen Deehan & Iain Martin. (2012) Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain. Bioorganic & Medicinal Chemistry Letters 22:8, pages 2932-2937.
Crossref
Crossref
R. B. Raffa & J. V. Pergolizzi Jr. (2011) Deciphering the mechanism(s) of action of natural products: analgesic peroxide oil as example. Journal of Clinical Pharmacy and Therapeutics 36:3, pages 283-298.
Crossref
Crossref
Robert J. Gleave, Paul J. Beswick, Andrew J. Brown, Gerard M.P. Giblin, Paul Goldsmith, Carl P. Haslam, William L. Mitchell, Neville H. Nicholson, Lee W. Page, Sadhana Patel, Susan Roomans, Brian P. Slingsby & Martin E. Swarbrick. (2010) Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB2 agonists for the treatment of inflammatory pain. Bioorganic & Medicinal Chemistry Letters 20:2, pages 465-468.
Crossref
Crossref
Robert J. Gleave, Paul J. Beswick, Andrew J. Brown, Gerard M.P. Giblin, Carl P. Haslam, David Livermore, Andrew Moses, Neville H. Nicholson, Lee W. Page, Brian Slingsby & Martin E. Swarbrick. (2009) 2-Amino-5-aryl-pyridines as selective CB2 agonists: Synthesis and investigation of structure–activity relationships. Bioorganic & Medicinal Chemistry Letters 19:23, pages 6578-6581.
Crossref
Crossref
Saniya Aggarwal, Behnam Shavalian, Esther Kim & Scott M. Rawls. (2009) Agmatine enhances cannabinoid action in the hot-plate assay of thermal nociception. Pharmacology Biochemistry and Behavior 93:4, pages 426-432.
Crossref
Crossref
I Mancini, R Brusa, G Quadrato, C Foglia, P Scandroglio, LS Silverman, D Tulshian, A Reggiani & M Beltramo. (2009)
Constitutive activity of cannabinoid-2 (CB
2
) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242
. British Journal of Pharmacology 158:1, pages 382-391.
Crossref
Crossref
Ian W. Rodger. (2009) Analgesic targets: today and tomorrow. Inflammopharmacology 17:3, pages 151-161.
Crossref
Crossref
Jörg Ahrens, Martin Leuwer, Reyhan Demir, Klaus Krampfl, Jeanne de la Roche, Nilufar Foadi, Matthias Karst & Gertrud Haeseler. (2008) Positive allosteric modulatory effects of ajulemic acid at strychnine-sensitive glycine α1- and α1β-receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 379:4, pages 371-378.
Crossref
Crossref
Sumner H. Burstein & Robert B. Zurier. (2009) Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation. The AAPS Journal 11:1.
Crossref
Crossref
Mikael Brusberg, Susanne Arvidsson, Daiwu Kang, Håkan Larsson, Erik Lindström & Vicente Martinez. (2009)
CB
1
Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents
. The Journal of Neuroscience 29:5, pages 1554-1564.
Crossref
Crossref
Roger G Pertwee. (2009) Emerging strategies for exploiting cannabinoid receptor agonists as medicines. British Journal of Pharmacology 156:3, pages 397-411.
Crossref
Crossref
Betty B. Yao, Gin Hsieh, Anthony V. Daza, Yihong Fan, George K. Grayson, Tiffany Runyan Garrison, Odile El Kouhen, Bradley A. Hooker, Madhavi Pai, Erica J. Wensink, Anita K. Salyers, Prasant Chandran, Chang Z. Zhu, Chengmin Zhong, Keith Ryther, Megan E. Gallagher, Chih-Liang Chin, Ann E. Tovcimak, Vincent P. Hradil, Gerard B. Fox, Michael J. Dart, Prisca Honore & Michael D. Meyer. (2009)
Characterization of a Cannabinoid CB
2
Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3
H
-thiazol-(2
Z
)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging
. Journal of Pharmacology and Experimental Therapeutics 328:1, pages 141-151.
Crossref
Crossref
Isaac E. Marx, Erin F. DiMauro, Alan Cheng, Renee Emkey, Stephen A. Hitchcock, Liyue Huang, Ming Y. Huang, Jason Human, Josie H. Lee, Xingwen Li, Matthew W. Martin, Ryan D. White, Robert T. FremeauJr.Jr. & Vinod F. Patel. (2009) Discovery of ?-amidosulfones as potent and selective agonists of CB2: Synthesis, SAR, and pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters 19:1, pages 31-35.
Crossref
Crossref
Roger G. Pertwee & Adèle Thomas. 2009. The Cannabinoid Receptors. The Cannabinoid Receptors
361
392
.
Penny C. Staton, Jon P. Hatcher, Deborah J. Walker, Alastair D. Morrison, Ellen M. Shapland, Jane P. Hughes, Elizabeth Chong, Palwinder K. Mander, Paula J. Green, Andy Billinton, Michael Fulleylove, Hilary C. Lancaster, Jason C. Smith, Leigh T. Bailey, Alan Wise, Andrew J. Brown, Jill C. Richardson & Iain P. Chessell. (2008) The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain 139:1, pages 225-236.
Crossref
Crossref
Christophe Mallet, Laurence Daulhac, Jérôme Bonnefont, Catherine Ledent, Monique Etienne, Eric Chapuy, Frédéric Libert & Alain Eschalier. (2008) Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain 139:1, pages 190-200.
Crossref
Crossref
Yuan Cheng, Brian K. Albrecht, James Brown, John L. Buchanan, William H. Buckner, Erin F. DiMauro, Renee Emkey, Robert T. FremeauJr.Jr., Jean-Christophe Harmange, Beth J. Hoffman, Liyue Huang, Ming Huang, Josie Han Lee, Fen-Fen Lin, Matthew W. Martin, Hung Q. Nguyen, Vinod F. Patel, Susan A. Tomlinson, Ryan D. White, Xiaoyang Xia & Stephen A. Hitchcock. (2008)
Discovery and Optimization of a Novel Series of
N
-Arylamide Oxadiazoles as Potent, Highly Selective and Orally Bioavailable Cannabinoid Receptor 2 (CB
2
) Agonists
. Journal of Medicinal Chemistry 51:16, pages 5019-5034.
Crossref
Crossref
A. Dray. (2008) Neuropathic pain: emerging treatments. British Journal of Anaesthesia 101:1, pages 48-58.
Crossref
Crossref
Roger G. Pertwee. (2008) Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addiction Biology 13:2, pages 147-159.
Crossref
Crossref
Andy Dray. (2008) New Horizons in Pharmacologic Treatment for Rheumatic Disease Pain. Rheumatic Disease Clinics of North America 34:2, pages 481-505.
Crossref
Crossref
B B Yao, G C Hsieh, J M Frost, Y Fan, T R Garrison, A V Daza, G K Grayson, C Z Zhu, M Pai, P Chandran, A K Salyers, E J Wensink, P Honore, J P Sullivan, M J Dart & M D Meyer. (2008)
In vitro
and
in vivo
characterization of A-796260: a selective cannabinoid CB
2
receptor agonist exhibiting analgesic activity in rodent pain models
. British Journal of Pharmacology 153:2, pages 390-401.
Crossref
Crossref
R G Pertwee. (2008)
The diverse CB
1
and CB
2
receptor pharmacology of three plant cannabinoids: Δ
9
-tetrahydrocannabinol, cannabidiol and Δ
9
-tetrahydrocannabivarin
. British Journal of Pharmacology 153:2, pages 199-215.
Crossref
Crossref
A. Dray. 2008. The Senses: A Comprehensive Reference. The Senses: A Comprehensive Reference
795
819
.
Andrea S. HeimannIvone GomesCamila S. DaleRosana L. PaganoAchla GuptaLaura L. de SouzaAugusto D. LuchessiLeandro M. Castro, Renata GiorgiVanessa Rioli, Emer S. Ferro & Lakshmi A. Devi. (2007)
Hemopressin is an inverse agonist of CB
1
cannabinoid receptors
. Proceedings of the National Academy of Sciences 104:51, pages 20588-20593.
Crossref
Crossref
Pedro Emilio Bermejo Velasco & Rocío Velasco Calvo. (2007) Nuevos fármacos antiepilépticos y dolor neuropático. De la medicina molecular a la clínica. Medicina Clínica 129:14, pages 542-550.
Crossref
Crossref
a. a. izzo. (2007)
The cannabinoid CB
2
receptor: a good friend in the gut
. Neurogastroenterology & Motility 19:9, pages 704-708.
Crossref
Crossref
k. hillsley, c. mccaul, j. aerssens, p. j. peeters, h. gijsen, d. moechars, b. coulie, d. grundy & r. h. stead. (2007) Activation of the cannabinoid 2 (CB2) receptor inhibits murine mesenteric afferent nerve activity. Neurogastroenterology & Motility 19:9, pages 769-777.
Crossref
Crossref
Ken Mackie. (2007) From Active Ingredients to the Discovery of the Targets: The Cannabinoid Receptors. Chemistry & Biodiversity 4:8, pages 1693-1706.
Crossref
Crossref
Tuba Esfandyari, Michael Camilleri, Irene Busciglio, Duane Burton, Kari Baxter & Alan R. Zinsmeister. (2007) Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. American Journal of Physiology-Gastrointestinal and Liver Physiology 293:1, pages G137-G145.
Crossref
Crossref
S.Y. Sit, Charlie Conway, Robert Bertekap, Kai Xie, Clotilde Bourin, Kevin Burris & Hongfeng Deng. (2007) Novel inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters 17:12, pages 3287-3291.
Crossref
Crossref
Pál Pacher, Sándor Bátkai & George Kunos. (2006) The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacological Reviews 58:3, pages 389-462.
Crossref
Crossref
B B Yao, S Mukherjee, Y Fan, T R Garrison, A V Daza, G K Grayson, B A Hooker, M J Dart, J P Sullivan & M D Meyer. (2006)
In vitro
pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB
2
receptor?
. British Journal of Pharmacology 149:2, pages 145-154.
Crossref
Crossref